vs
Side-by-side financial comparison of SciSparc Ltd. (SPRC) and ScanTech AI Systems Inc. (STAI). Click either name above to swap in a different company.
ScanTech AI Systems Inc. is the larger business by last-quarter revenue ($631.0K vs $461.0K, roughly 1.4× SciSparc Ltd.). ScanTech AI Systems Inc. runs the higher net margin — -1532.9% vs -2041.6%, a 508.8% gap on every dollar of revenue.
SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapies for unmet medical needs in the neurological, psychiatric, and gastrointestinal disorder segments. It operates across global biotech markets, leveraging proprietary cannabinoid-based formulation technologies to advance its pipeline of therapeutic candidates.
SPRC vs STAI — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $461.0K | $631.0K |
| Net Profit | $-9.4M | $-9.7M |
| Gross Margin | 78.1% | 27.6% |
| Operating Margin | -588.5% | -773.2% |
| Net Margin | -2041.6% | -1532.9% |
| Revenue YoY | -45.1% | — |
| Net Profit YoY | -155.8% | — |
| EPS (diluted) | $17.92 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $631.0K | ||
| Q2 25 | $461.0K | $884.0K | ||
| Q1 25 | — | $346.1K | ||
| Q4 24 | $466.0K | — | ||
| Q2 24 | $840.0K | — | ||
| Q2 23 | $2.0M | — |
| Q3 25 | — | $-9.7M | ||
| Q2 25 | $-9.4M | $-6.9M | ||
| Q1 25 | — | $-17.9M | ||
| Q4 24 | $-3.8M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q2 23 | $-2.9M | — |
| Q3 25 | — | 27.6% | ||
| Q2 25 | 78.1% | 14.3% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | 6.9% | — | ||
| Q2 24 | 56.4% | — | ||
| Q2 23 | 74.2% | — |
| Q3 25 | — | -773.2% | ||
| Q2 25 | -588.5% | -440.1% | ||
| Q1 25 | — | -4503.9% | ||
| Q4 24 | -813.1% | — | ||
| Q2 24 | -419.9% | — | ||
| Q2 23 | -150.5% | — |
| Q3 25 | — | -1532.9% | ||
| Q2 25 | -2041.6% | -785.1% | ||
| Q1 25 | — | -5174.2% | ||
| Q4 24 | -813.9% | — | ||
| Q2 24 | -438.0% | — | ||
| Q2 23 | -148.7% | — |
| Q3 25 | — | $-0.16 | ||
| Q2 25 | $17.92 | $-0.16 | ||
| Q1 25 | — | $-0.77 | ||
| Q4 24 | $-8.82 | — | ||
| Q2 24 | $35.70 | — | ||
| Q2 23 | $10.85 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | — |
| Total DebtLower is stronger | — | $17.7M |
| Stockholders' EquityBook value | $-81.0K | — |
| Total Assets | $5.1M | $5.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5M | — | ||
| Q2 24 | $252.0K | — | ||
| Q2 23 | $2.1M | — |
| Q3 25 | — | $17.7M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $17.7M | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | $-81.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.9M | — | ||
| Q2 24 | $8.7M | — | ||
| Q2 23 | $6.8M | — |
| Q3 25 | — | $5.1M | ||
| Q2 25 | $5.1M | $4.6M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | $10.3M | — | ||
| Q2 24 | $10.5M | — | ||
| Q2 23 | $9.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.9M | $-758.5K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-758.5K | ||
| Q2 25 | $-1.9M | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | $-2.9M | — | ||
| Q2 24 | $-2.2M | — | ||
| Q2 23 | $-3.2M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | — | — | ||
| Q2 24 | $-2.2M | — | ||
| Q2 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -166.0% | ||
| Q1 25 | — | -623.8% | ||
| Q4 24 | — | — | ||
| Q2 24 | -261.7% | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
